Skip to content

Clinical trials

Diabetes Insipidus trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Insipidus Clear all

190 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20032
20042
20067
20072
200812
20094
20105
201119
201212
20138
20144
20158
201615
201710
20189
20197
20203
20218
20227
20238
202416
20256
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119
Unknown status27
Recruiting23
Withdrawn7
Terminated7
Not yet recruiting5
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland25
University of Electronic Science and Technology of China7
Charite University, Berlin, Germany3
National Center for Research Resources (NCRR)3
National Institute of Mental Health (NIMH)3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Region Skane3
Washington University School of Medicine3
Arizona State University2
Assistance Publique - Hôpitaux de Paris2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Insipidus190
Shock, Septic21
Hyponatremia14
Diabetes Insipidus, Neurogenic13
Inappropriate ADH Syndrome10
Hemorrhage8
Shock8
Polydipsia, Psychogenic7
Sepsis7
Heart Failure6

Trials

Showing 51 to 75 of 190. Each trial links to its page on Pharma Observatory.

90 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.